Related Experiment Video

Updated: Aug 4, 2026

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Novel expression of cyclin-dependent kinase inhibitors in human B-cell precursors

J R Fink1, T W LeBien

  • 1Department of Laboratory Medicine/Pathology, University of Minnesota Cancer Center, 420 Delaware Street S.E., Minneapolis, MN 55455, USA.

Experimental Hematology
|April 13, 2001
PubMed

Insights

Deletions in the INK4a gene occur in B-lineage acute lymphoblastic leukemia (ALL). However, the related INK4d protein is widely expressed in normal B-cells, potentially compensating for INK4a loss in ALL progression.

Area of Science:

  • Cell Biology
  • Cancer Biology
  • Hematology

Background:

  • Eukaryotic cell division relies on cyclins, cyclin-dependent kinases (CDKs), and cyclin-dependent kinase inhibitors (CKIs).
  • Mutations in these regulatory genes are common in cancers, including B-lineage acute lymphoblastic leukemia (ALL), where INK4a deletions are observed in 20-30% of cases.
  • The precise role of INK4a deletions in B-lineage ALL progression remains unclear due to limited data on its expression in normal B-cell precursors.

Purpose of the Study:

  • To compare the expression of cyclins, CDKs, and CKIs in normal human B-cell development and B-lineage ALL.
  • To investigate the potential compensatory role of other CKIs, such as INK4d, in the context of INK4a loss in ALL.

Main Methods:

  • Purification of normal human B-cell development stages from bone marrow using fluorescence-activated cell sorting.
  • Analysis of cyclin, CDK, and CKI expression in sorted normal B-cells and B-lineage ALL cell lines (BLIN-1-4) via reverse transcriptase polymerase chain reaction (RT-PCR) and Western blotting.

Main Results:

  • Cyclin D2, D3, CDK4, and CDK6 were ubiquitously expressed in both normal B-cell development and ALL cell lines.
  • The p19(INK4d) CKI was the most consistently expressed INK4 family member, while p16(INK4a) showed weak and variable expression.
  • p19(INK4d) was ubiquitously expressed in normal B-lineage cells, a finding not previously described.
  • Western blotting confirmed CDK4, CDK6, p19(INK4d), and p57(KIP2) expression in normal B-cell precursors, with p16(INK4a) undetectable.

Conclusions:

  • Expression patterns of Cyclin D/CDK complexes are similar in normal and leukemic human B-cell precursors and mature B cells.
  • The widespread expression of p19(INK4d) in normal B-lineage cells suggests it may compensate for the loss of p16(INK4a) in B-lineage ALL.
  • Loss of INK4a may have a minimal impact on B-lineage ALL progression due to the potential compensatory function of INK4d.

More Related Videos

Preparation of Primary Acute Lymphoblastic Leukemia Cells in Different Cell Cycle Phases by Centrifugal Elutriation09:09

Preparation of Primary Acute Lymphoblastic Leukemia Cells in Different Cell Cycle Phases by Centrifugal Elutriation

Published on: November 10, 2017

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

Related Concept Videos

Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...